Literature DB >> 25108165

Early reperfusion injury is associated to MMP2 and IL-1β elevation in cortical neurons of rats subjected to middle cerebral artery occlusion.

D Amantea1, M Certo2, R Russo2, G Bagetta2, M T Corasaniti3, C Tassorelli4.   

Abstract

The pathophysiological processes implicated in ischemic brain damage are strongly affected by an inflammatory reaction characterized by activation of immune cells and release of soluble mediators, including cytokines and chemokines. The pro-inflammatory cytokine interleukin (IL)-1β has been implicated in ischemic brain injury, however, to date, the mechanisms involved in the maturation of this cytokine in the ischemic brain have not been completely elucidated. We have previously suggested that matrix metalloproteinases (MMPs) may be implicated in cytokine production under pathological conditions. Here, we demonstrate that significant elevation of IL-1β occurs in the cortex as early as 1h after the beginning of reperfusion in rats subjected to 2-h middle cerebral artery occlusion (MCAo). At this early stage, we observe increased expression of IL-1β in pericallosal astroglial cells and in cortical neurons and this latter signal colocalizes with elevated gelatinolytic activity. By gel zymography, we demonstrate that the increased gelatinolytic signal at 1-h reperfusion is mainly ascribed to MMP2. Thus, MMP2 seems to contribute to early brain elevation of IL-β after transient ischemia and this mechanism may promote damage since pharmacological inhibition of gelatinases by the selective MMP2/MMP9 inhibitor V provides neuroprotection in rats subjected to transient MCAo.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IL-1β; brain ischemia; matrix metalloproteinases; neuroinflammation

Mesh:

Substances:

Year:  2014        PMID: 25108165     DOI: 10.1016/j.neuroscience.2014.07.064

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

1.  Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.

Authors:  Diana Amantea; Michelangelo Certo; Francesco Petrelli; Giacinto Bagetta
Journal:  Assay Drug Dev Technol       Date:  2016-07-08       Impact factor: 1.738

2.  Selective knockout of astrocytic Na+ /H+ exchanger isoform 1 reduces astrogliosis, BBB damage, infarction, and improves neurological function after ischemic stroke.

Authors:  Gulnaz Begum; Shanshan Song; Shaoxia Wang; Hanshu Zhao; Mohammad Iqbal H Bhuiyan; Eric Li; Rachel Nepomuceno; Qing Ye; Ming Sun; Michael Joseph Calderon; Donna B Stolz; Claudette St Croix; Simon C Watkins; Yinhuai Chen; Pingnian He; Gary E Shull; Dandan Sun
Journal:  Glia       Date:  2017-09-19       Impact factor: 7.452

3.  Temporal analysis of blood-brain barrier disruption and cerebrospinal fluid matrix metalloproteinases in rhesus monkeys subjected to transient ischemic stroke.

Authors:  Yingqian Zhang; Feng Fan; Guojun Zeng; Linlin Zhou; Yinbing Zhang; Jie Zhang; He Jiao; Ting Zhang; Dan Su; Cheng Yang; Xin Wang; Kai Xiao; Hongxia Li; Zhihui Zhong
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 4.  Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures?

Authors:  Aditya Rayasam; Martin Hsu; Julie A Kijak; Lee Kissel; Gianna Hernandez; Matyas Sandor; Zsuzsanna Fabry
Journal:  Immunology       Date:  2018-03-26       Impact factor: 7.397

5.  IL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac Allografts.

Authors:  Shoichi Iida; Hidetoshi Tsuda; Toshiaki Tanaka; Danielle D Kish; Toyofumi Abe; Charles A Su; Ryo Abe; Kazunari Tanabe; Anna Valujskikh; William M Baldwin; Robert L Fairchild
Journal:  J Immunol       Date:  2016-02-08       Impact factor: 5.422

Review 6.  Matrix metalloproteinases as therapeutic targets for stroke.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Brain Res       Date:  2015-04-25       Impact factor: 3.252

Review 7.  Rational modulation of the innate immune system for neuroprotection in ischemic stroke.

Authors:  Diana Amantea; Giuseppe Micieli; Cristina Tassorelli; María I Cuartero; Iván Ballesteros; Michelangelo Certo; María A Moro; Ignacio Lizasoain; Giacinto Bagetta
Journal:  Front Neurosci       Date:  2015-04-29       Impact factor: 4.677

Review 8.  Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke.

Authors:  Shihoko Kimura-Ohba; Yi Yang
Journal:  Oxid Med Cell Longev       Date:  2016-01-27       Impact factor: 6.543

Review 9.  Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells.

Authors:  Dusica Maysinger; Jeff Ji; Eliza Hutter; Elis Cooper
Journal:  Front Neurosci       Date:  2015-12-18       Impact factor: 4.677

10.  Molecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic Brain.

Authors:  Chi-Hsin Lin; Chen-Hsuan Wang; Shih-Lan Hsu; Li-Ya Liao; Ting-An Lin; Chi-Mei Hsueh
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.